Products
- Anti-Obesity Compound Library
- GPCR/G Protein-Targeted Compounds
- Immunology/Inflammation-Targeted Compounds
- JAK/STAT-Targeted Compounds
- MAPK-Targeted Compounds
- Membrane Transporter/Ion Channel-Targeted Compounds
- Metabolism-Targeted Compounds
- NF-κB-Targeted Compounds
- Microbiology/Virology-Targeted Compounds
- Neuronal Signaling-Targeted Compounds
- PI3K/Akt/mTOR-Targeted Compounds
- Oxidation-reduction-Targeted Compounds
- Proteases/Proteasome-Targeted Compounds
- Stem Cells/Wnt-Targeted Compounds
- Tyrosine Kinase/Adaptors-Targeted Compounds
- Ubiquitin-Targeted Compounds
Online Inquiry
Sodium salicylate
Cat. No.:
0225LY-0508
Appearance:
Solid
Purity:
≥99%
Identity:
Confirmed by NMR, and LC-MS.
Size:
Add to basket
Product Overview
Description:
Sodium salicylate is an acetylsalicylic acid metabolite that helps minimize oxidative stress and suppress NF-kB signaling.
Synonym:
Salicylic acid sodium salt; 2-Hydroxybenzoic acid sodium salt; 54-21-7; Diuretin; Monosodium 2-hydroxybenzoate
CAS No.:
54-21-7
Compound CID:
16760658
Formula:
C7H5NaO3
Formula Weight:
160.11
Specification
Relative Density:
0.56 g/cm3 at 25°C.
Stability:
3 years in powder form.
Storage:
Storage at -20°C.
Applications:
Sodium salicylate can be used in biochemical assays to study the inhibition of NF-kappaB and its impact on inflammatory responses.
Library Information
Target:
NF-κB; COX; S6 Kinase
Receptor:
COX-1; COX-3; NF-κB; RSK
Pathways:
Immunology/Inflammation; Apoptosis; PI3K/Akt/mTOR signaling; Autophagy; MAPK; NF-κB; Neuronal signaling
Plate Number:
AOCL-7
Plate Location:
e10
Empty Location:
a1-h1; a12-h12
Container:
96-well plate
Formulation:
10mM DMSO
DMSO Max Solubility:
166.67 mg/mL; 1040.97 mM
Water Max Solubility:
29 mg/mL; 181.13 mM
Ethanol Max Solubility:
<1 mg/mL
ALogP:
1.217
HBA_Count:
1
HBD_Count:
1
Rotatable Bond:
1
